Journey Medical Corp (DERM)
3.84 +0.11 (+2.95%) 01/15/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Jan 15th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -3,853 | -29,628 | -43,994 | 5,283 | 3,625 |
Depreciation Amortization | 7,354 | 4,428 | 5,132 | 1,516 | 1,264 |
Income taxes - deferred | N/A | N/A | 1,566 | -335 | 69 |
Accounts receivable | 12,551 | -5,380 | 768 | -5,022 | -10,492 |
Accounts payable and accrued liabilities | -18,639 | 14,115 | 22,257 | -152 | 1,148 |
Other Working Capital | -1,655 | 6,187 | 14,709 | -2,232 | 3,465 |
Other Operating Activity | 9,482 | -3,256 | -2,619 | 6,074 | 9,939 |
Operating Cash Flow | $5,240 | $-13,534 | $-2,181 | $5,132 | $9,018 |
Cash Flows From Investing Activities | |||||
Purchase Sale Intangibles | -5,000 | -20,000 | -10,000 | -1,200 | -2,400 |
Other Investing Activity | -5,000 | -20,000 | -10,000 | -1,200 | -2,400 |
Investing Cash Flow | $-5,000 | $-20,000 | $-10,000 | $-1,200 | $-2,400 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 28,000 | 5,000 | 16,540 | 0 | 449 |
Debt Issued | 15,000 | 19,763 | 0 | N/A | N/A |
Debt Repayment | -21,000 | -5,000 | -5,300 | -500 | N/A |
Common Stock Issued | 4,615 | 142 | 32,543 | 13 | N/A |
Other Financing Activity | -31,419 | -3,449 | 9,233 | 0 | -4,000 |
Financing Cash Flow | $-4,804 | $16,456 | $53,016 | $-487 | $-3,551 |
Beginning Cash Position | 32,003 | 49,081 | 8,246 | 4,801 | 1,734 |
End Cash Position | 27,439 | 32,003 | 49,081 | 8,246 | 4,801 |
Net Cash Flow | $-4,564 | $-17,078 | $40,835 | $3,445 | $3,067 |
Free Cash Flow | |||||
Operating Cash Flow | 5,240 | -13,534 | -2,181 | 5,132 | 9,018 |
Free Cash Flow | 5,240 | -13,534 | -2,181 | 5,132 | 9,018 |